KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Interest Expenses: 2009-2025

Historic Interest Expenses for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $412.0 million.

  • Bausch Health Companies' Interest Expenses rose 19.08% to $412.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 9.19%. This contributed to the annual value of $1.4 billion for FY2024, which is 4.52% up from last year.
  • As of Q3 2025, Bausch Health Companies' Interest Expenses stood at $412.0 million, which was down 11.40% from $465.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Interest Expenses high stood at $465.0 million for Q2 2025, and its period low was $307.0 million during Q4 2022.
  • Moreover, its 3-year median value for Interest Expenses was $346.0 million (2024), whereas its average is $356.6 million.
  • In the last 5 years, Bausch Health Companies' Interest Expenses fell by 22.20% in 2023 and then skyrocketed by 32.86% in 2025.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Interest Expenses stood at $343.0 million in 2021, then declined by 10.50% to $307.0 million in 2022, then climbed by 18.24% to $363.0 million in 2023, then fell by 7.16% to $337.0 million in 2024, then grew by 19.08% to $412.0 million in 2025.
  • Its Interest Expenses stands at $412.0 million for Q3 2025, versus $465.0 million for Q2 2025 and $330.0 million for Q1 2025.